Tab Application Banner
  • Users Online: 2
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
 
ORIGINAL ARTICLE
Ahead of Print

Comparison of intra articular autologous platelet-rich plasma with steroids in osteoarthritis knee: Experience from a North Indian tertiary care center


1 Department of Rheumatolgy and Clinical Immunology, Command Hospital (Central Command) Lucknow, Uttar Pradesh, India
2 Department of Rheumatology, Army Hospital (Research & Referral), New Delhi, India
3 Department of Rheumatology, Command Hospital, Pune, India
4 Department of Medicine, Sree Balaji Medical college and Hospital, Chennai, India
5 Department of Rheumatology, Command Hospital, Kolkata, West Bengal, India
6 Department of Radiology, Army Hospital (Research & Referral), New Delhi, India
7 Centre for Chronic Disease Control, PHFI, Gurgaon, Haryana, India

Correspondence Address:
MN Arjun,
Department of Rheumatolgy and Clinical Immunology, Command Hospital (Central Command) Lucknow, Uttar Pradesh -226 002
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/injr.injr_159_19

Background: Intra-articular (IA) platelet-rich plasma (PRP) is a promising treatment option for knee osteoarthritis (OA). It accelerates the process of healing, ligament repair, cartilage regeneration, and bone formation when given in supraphysiological doses. The aim of this study was to compare the efficacy of IA PRP versus IA methylprednisolone acetate (MPA) in patients with knee OA. Methods: Open labeled prospective observational study was conducted on 60 patients with Kellgren-Lawrence Grade 2 and 3 OA knee, who fulfilled the ACR classification criteria for knee OA. Thirty patients were given IA PRP (6 ml) and 30 received IA methyl prednisolone (80 mg) at baseline line, which was repeated at 12 weeks. The primary endpoint was an improvement in Western Ontario and McMaster Universities Index (WOMAC) and 100 mm Visual Analog Scale (VAS) pain at 24 weeks postinjections. Results: The mean change in VAS pain and total WOMAC score from baseline to 24 weeks was 32.9 ± 12.1, 31.8 ± 14.7 for PRP group, and 12.9 ± 5.9, 7.5 ± 5.5 for MPA group, which was statistically significant (P < 0.0001). Conclusions: Treatment with IA PRP showed sustained improvements in WOMAC and VAS scores compared to IA steroids. PRP is an effective treatment for functional status and pain in moderate knee osteoarthritis.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Arjun M N
    -  Vasdev V
    -  Kishore K
    -  Hegde A
    -  Shanmuganandan K
    -  Kumar A
    -  Kovilapu UB
    -  Shivashankar R
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed40    
    PDF Downloaded7    

Recommend this journal